Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. Roth A, Barcellini W, D'Sa S, Miyakawa Y, et al. Am J Hematol 2023;98:1246-1253.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Roth A, Barcellini W, D'Sa S, Miyakawa Y, et al. Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. Am J Hematol 2023;98:1246-1253.
PMID: 37246953